Pharmacokinetics of buprenorphine following intravenous and buccal administration in cats, and effects on thermal threshold

This study reports the pharmacokinetics of buprenorphine, following i.v. and buccal administration, and the relationship between buprenorphine concentration and its effect on thermal threshold. Buprenorphine (20g/kg) was administered intravenously or buccally to six cats. Thermal threshold was determined, and arterial blood sampled prior to, and at various times up to 24h following drug administration. Plasma buprenorphine concentration was determined using liquid chromatography/mass spectrometry. Compartment models were fitted to the time-concentration data. Pharmacokinetic/pharmacodynamic models were fitted to the concentration-thermal threshold data. Thermal threshold was significantly higher than baseline 44min after buccal administration, and 7, 24, and 104min after i.v. administration. A two- and three-compartment model best fitted the data following buccal and i.v. administration, respectively. Following i.v. administration, mean +/- SD volume of distribution at steady-state (L/kg), clearance (mLmin/kg), and terminal half-life (h) were 11.6 +/- 8.5, 23.8 +/- 3.5, and 9.8 +/- 3.5. Following buccal administration, absorption half-life was 23.7 +/- 9.1min, and terminal half-life was 8.9 +/- 4.9h. An effect-compartment model with a simple effect maximum model best predicted the time-course of the effect of buprenorphine on thermal threshold. Median (range) k(e0) and EC50 were 0.003 (0.002-0.018)/min and 0.599 (0.073-1.628) ng/mL (i.v.), and 0.017 (0.002-0.023)/min and 0.429 (0.144-0.556) ng/mL (buccal).